Results 141 to 150 of about 5,332,775 (244)

SGLT‐2 Inhibitors are Associated With a Lower Risk of Multiple Myeloma

European Journal of Haematology, Volume 117, Issue 5, Page 1347-1357, November 2026.
ABSTRACT Aims We aimed to investigate drug response of sodium‐glucose transport protein‐2 inhibitors (SGLT2i) in multiple myeloma (MM), as SGLT2i have potential favorable effects on conditions related to MM. Methods We conducted a pharmacoepidemiologic study with a US nationwide health insurance claim data using Cox models to investigate the ...
Enze Liu, Anna Sun, Yuedi Yang, Jing Xu, Attaya Suvannasankha, Brian A. Walker, Pengyue Zhang   +6 more
wiley   +1 more source

Treatment Outcomes of Perforated Peptic Ulcer Disease and Associated Factors Among Patients Treated in Jimma University Medical Center, Jimma, Ethiopia

Peptic ulcer perforation is one of the acute complications of peptic ulcer disease with significant morbidity and mortality.
Nebiyou Simegnew, Osias Tilahun, Tofik Yassin   +2 more
core  

Review of Peptic Ulcer Disease: Insights from Pathophysiology, Mechanisms, Pharmacotherapy, Phytotherapy, and Case Reports. [PDF]

Drug Des Devel Ther
Pertiwi R, Wilar G, Sumiwi SA, Levita J.
europepmc   +1 more source

Retrospective comparison of treatments for equine gastric ulceration syndrome and the influence of inflammatory bowel disease

Equine Veterinary Education, Volume 38, Issue 11, Page e882-e891, November 2026.
Summary Background Equine squamous gastric disease (ESGD) and equine glandular gastric disease (EGGD) can be treated with oral omeprazole, combined with sucralfate or an extended‐release intramuscular omeprazole (ERIO). Objectives To evaluate these different treatments for ESGD and EGGD and assess the influence of inflammatory bowel disease (IBD) on ...
L. C. Kranenburg, C. Ludin, D. A. van Doorn, M. M. Sloet van Oldruitenborgh‐Oosterbaan, P. Witt, R. M. A. C. Houben, R. van den Boom   +6 more
wiley   +1 more source

Eradication of Helicobacter pylori in the Treatment of Uncomplicated Peptic Ulcer Disease

At least 95% of patients with duodenal ulcers and 80% of patients with gastric ulcers are infected with Helicobacter pylori. H. pylori is clearly recognised as the major culprit involved in the pathophysiology of peptic ulcer disease.
William E. Wade, Mark W. Jackson, Marie A. Chisholm   +2 more
core  

Treatment outcomes and determinants of refractory peptic ulcer disease in children: A prospective study from Vietnam. [PDF]

J Pediatr Gastroenterol Nutr
Chu TPM, Tran THT, Do TMP, Nguyen VT, Nguyen L, Nguyen TTH, Nguyen TTT, Hoang TBN, Hoang NT, Nguyen TVH.   +9 more
europepmc   +1 more source

Lack of Usefulness of Literature‐Based Helicobacter pylori Resistance Data for Predicting First‐Line Empirical Treatment Effectiveness in the European Registry on H. pylori Management (Hp‐EuReg)

Helicobacter, Volume 31, Issue 6, November/December 2026.
ABSTRACT Background Helicobacter pylori (H. pylori) infection causes gastritis, peptic ulcer disease, and gastric cancer. Without an effective vaccine, eradication therapy remains crucial. However, increasing antibiotic resistance compromises treatment effectiveness.
Ismail Kirrout, Olga P. Nyssen, Ángeles Pérez‐Aísa, Bojan Tepes, Irina N. Voynovan, Samuel J. Martínez‐Domínguez, Alfredo J. Lucendo, Ludmila G. Vologzanina, Matteo Pavoni, Sayar R. Abdulkhakov, Maja Denkovski, Javier Tejedor‐Tejada, Tatiana Ilchishina, Luis Bujanda, Aiman S. Sarsenbaeva, Jose M. Huguet, Oleg Zaytsev, Boris D. Starostin, Monica Perona, Antonietta G. Gravina, Manuel Pabón‐Carrasco, Sergey A. Alekseenko, Óscar Núñez, Miguel Areia, Jesús Barrio, Antonio Moreno Loro, Dmitry N. Andreev, Blas José Gómez Rodríguez, María Soledad Marcos, Inmaculada Ortiz‐Polo, Galina N. Tarasova, Igor Bakulin, Mónica Sánchez Alonso, Irene Arteagoitia, Virginia Flores, Manuel Jiménez‐Moreno, Dmitry S. Bordin, Antonio Gasbarrini, Ricardo Marcos‐Pinto, Wojciech Marlicz, Perminder S. Phull, Marino Venerito, Doron Boltin, Lyudmila Boyanova, Pablo Parra, Leticia Moreira, Francis Mégraud, Colm O'Morain, Nuria Montes, Javier P. Gisbert, on behalf of the Hp‐EuReg investigators, Natalia N. Dekhnich, Pilar Mata‐Romero, Natalia Valerievna Bakulina, Alla G. Kononova, Giuseppe Losurdo, Judith Gomez‐Camarero, Alma Keco‐Huerga, Pablo M. Wolfe García, Jurij Bednarik, Eduardo Iyo, Antonia Perelló, Luis Fernández‐Salazar, Noelia Alcaide, Benito Velayos, Pedro Almela, Ramón Pajares Villarroya, Daniel Martin‐Holgado, Miguel Fernández‐Bermejo, Ian L. P. Beales, Alisan Kahraman, Ana Beatriz Pozo Blanco, Montserrat Planella, Mikel Ganuza, Victor A. Kamburov, Marina F. Osipenko, Debora Compare, Georges Kamtoh, Rosa Rosania, Eva Barreiro Alonso, Maria A. Livzan, Teresa Angueira, Consuelo Ramírez, Piotr Szredzki, Natalia Baryshnikova, Natalia Bakanova, Pedro Delgado Guillena, Sheyla Montori Pina, Eduardo Albéniz, Piotr Eder, Inna V. Savilova, Henrique Fernandes‐Mendes, Miguel Suárez Matías, María Badía Martínez, Liya Nikolaevna Belousova, Benito Hermida Pérez, Ana Garre, Natasa Brglez Jurecic, Olga Kolokolnikova, Paola Chaudarcas, Luis Hernández, Regina I. Khlynova, Antonio Cuadrado, Marta Pascual‐Mato, Ekaterina Y. Plotnikova, Mila Kovacheva‐Slavova, Ramiro Carreño Macián, Manon C. W. Spaander, Guillem Soy, Pilar Pazo Mejide, Sergio Gil Rojas, Carlos Maroto‐Martín, Francisco J. Rancel‐Medina, Diego Burgos‐Santamaría, Isabel Pérez‐Martínez, Giulia Fiorini, Teresa Valdés‐Lacasa, Riccardo Vasapolli, Rosa M. Sáiz‐Chumillas, Tamara Matysiak‐Budnik, Anna L. Pakhomova, Jorge Yebra Carmona, Diego Ledro Cano, Senador Moran Sanchez, Jan Bornschein, Pilar Bernal Checa, Antonio M. Caballero‐Mateos, Leticia Gimeno Pitarch, Ángela Martínez Herreros, Nerea Alonso‐Bilbao, Patricia Sanz‐Segura, Jose Xavier Segarra Ortega, Raquel García‐Sánchez, Alexander Link, Jesus M. Gonzalez‐Santiago, Laura Larrey Ruiz, Rodrigo Garcés‐Durán   +136 more
wiley   +1 more source

Peptic ulcer disease in hospitalized patients: a comprehensive risk factor analysis using a validated checklist. [PDF]

BMC Gastroenterol
Tahery N, Baghrobehbahani A, Mohammadzadeh R, Alaviyan A, Paygozar R, Ebrahimzadeh M, Shafiee M.   +6 more
europepmc   +1 more source

Susceptibility‐Guided Triple Therapy Achieves High Helicobacter pylori Eradication Regardless of Duration

Journal of Gastroenterology and Hepatology, Volume 41, Issue 11, Page 3433-3441, November 2026.
ABSTRACT Background and Aim Although clarithromycin resistance is a major cause of empirical triple therapy failure for Helicobacter pylori eradication, the clinical relevance of amoxicillin susceptibility remains uncertain. We first compared eradication outcomes between empirical and susceptibility‐guided tailored triple therapy and then evaluated the
Hoyoung Wang, Ji Yong Ahn, Hee Kyong Na, Kee Wook Jung, Jeong Hoon Lee, Do Hoon Kim, Kee Don Choi, Ho June Song, Gin Hyug Lee, Hwoon‐Yong Jung, Jung Mogg Kim   +10 more
wiley   +1 more source

The burden of peptic ulcer disease in China, 1990-2021: update from the GBD 2021 study. [PDF]

Ann Med
Guo BC, Niu GM, Li YH.
europepmc   +1 more source